Podcast Episode 10: What The Expanded CMS Guidelines Mean for your Medicare Patients

Guest Speakers:  Jesse Bushman, Director, Market Access, and Renee Taylor MS, RD, BC-ADM, CDCES, Director, Medical Science at Dexcom

Real-time real talk is intended for healthcare professionals in the US.

In this episode of Real-Time Real Talk our host, Cher Pastore MS, RD, CDCES, BC-ADM, is joined by Jesse Bushman, Director, Market Access, and Renee Taylor MS, RD, BC-ADM, CDCES, Director, Medical Science at Dexcom to discuss the recent update from Centers of Medicare & Medicaid Services (CMS) regarding the expanded guidelines for Continuous Glucose Monitoring (CGM) coverage. 

Our guests will go into detail about the new coverage criteria and what it means for people with Type 2 diabetes. They will explain the clinical evidence¹ that enabled this change, and how CGM predictive alerts can help minimize the risk of diabetes complications, including severe hypoglycemia².

About expanded Medicare guidelines

1. Martens T, Beck RW, Bailey R, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial. JAMA. 2021;325(22):2262–2272. doi:10.1001/jama.2021.7444
2. Acciaroli G, Welsh JB, Akturk HK. Mitigation of Rebound Hyperglycemia With Real-Time Continuous Glucose Monitoring Data and Predictive Alerts. J Diabetes Sci Technol. 2022 May;16(3):677-682. doi: 10.1177/1932296820982584. Epub 2021 Jan 5. PMID: 33401946; PMCID: PMC9294577.